Dr CEN XIANG | Medicinal Chemistry | Best Researcher Award |

Posted on by ScienceFather

Dr. CEN XIANG | Medicinal Chemistry | Best Researcher Award |

Tianjin university of science and technology, China

Professional Profiles:

SCOPUS

👨‍🎓 Bio Summary:

Dr. Cen Xiang is an accomplished researcher and lecturer specializing in medicinal chemistry, fermentation engineering, and pharmacology. With a strong academic background and extensive research experience, Dr. Xiang’s work focuses on designing innovative therapeutic compounds and exploring their applications in disease treatment. Known for publishing in high-impact journals, they have made significant contributions to cancer therapy, liver disease, and antioxidant studies, establishing themselves as a prominent figure in pharmaceutical research.

🎓 Educational Background:

Dr. Cen Xiang pursued their academic journey with a Bachelor’s degree in Pharmaceutical Preparation from South-Central Minzu University (2008-2012). They then advanced to a Master’s degree in Medicinal Chemistry at Tianjin University of Science and Technology (2012-2016), followed by a Ph.D. in Fermentation Engineering from the same institution (2017-2021). This progression highlights their dedication to mastering diverse aspects of pharmaceutical science.

🔍 Research Focus:

Dr. Xiang’s research centers on the design, synthesis, and evaluation of bioactive compounds for therapeutic purposes. Their studies have addressed critical healthcare challenges, such as cancer treatments, antioxidant therapies, and liver protection. Notable projects include the development of PEGylated conjugates for targeted cancer therapy, synthesis of chalcone derivatives for antioxidant activity, and exploring hepatoprotective compounds.

🏆 Honors & Awards:

Dr. Xiang’s academic excellence is reflected in numerous accolades, including a First-Class Doctoral Scholarship (2018-2019), Second-Class Doctoral Scholarships (2017-2018, 2019-2020), and multiple postgraduate and undergraduate academic scholarships. They also earned recognition in experimental skills competitions at both institutional and provincial levels.

💼 Professional Experience:

Dr. Xiang’s career spans academia and industry. They worked as a Pharmacology Engineer at Zhejiang Hisun Pharmaceutical Co., Ltd. and Hunan Xiangquan Pharmaceutical Co., Ltd. before advancing into academia as a Postdoctoral Researcher (2021-2023) and later as a Lecturer at Tianjin University of Science and Technology (2024-present). Their consultancy role at Zhongke Blue Ocean Technology Co., Ltd. further reflects their applied expertise.

📚 Top Noted Publications :

Title: Flavonoid derivatives treat dextran sodium sulfate-induced experimental colitis in mice by inhibiting MAPK/NF-κB pathway activation
Authors: Xiang, C., Qiu, Q., Zhang, C., Chang, Y., Teng, Y.-O.
Citations: 0
Index: European Journal of Medicinal Chemistry Reports
Year of Publication: 2024

Title: Cyclodextrin-based metal-organic frameworks transforming drug delivery
Authors: Yang, N., Wei, L., Teng, Y., Xiang, C., Liu, J.
Citations: 5
Index: European Journal of Medicinal Chemistry
Year of Publication: 2024

Title: G-4 inhibits triple negative breast cancer by inducing cell apoptosis and promoting LCN2-dependent ferroptosis
Authors: Sun, G., Wang, J., Liu, F., Yu, P., Teng, Y.
Citations: 2
Index: Biochemical Pharmacology
Year of Publication: 2024

Title: Podophyllotoxin-loaded PEGylated E-selectin peptide conjugate targeted cancer site to enhance tumor inhibition and reduce side effect
Authors: Xiang, C., Fu, Y., Hao, T., Yu, P., Teng, Y.-O.
Citations: 2
Index: European Journal of Medicinal Chemistry
Year of Publication: 2023

Title: Design, synthesis and anti-NASH effect evaluation of novel GFT505 derivatives in vitro and in vivo
Authors: Xiang, C., Chen, X., Yao, J., Yu, P., Teng, Y.-O.
Citations: 4
Index: European Journal of Medicinal Chemistry
Year of Publication: 2023

Conclusion:

Cen Xiang’s profile reflects a highly competent and dedicated researcher with a strong foundation in pharmaceutical and medicinal chemistry. Their contributions to antioxidant research, cancer therapeutics, and liver disease treatment are significant and have the potential for substantial societal impact. For the Best Researcher Award, their strengths in academic excellence, publication record, and applied research make them a deserving candidate. Strengthening global collaborations, leadership roles, and showcasing innovation outcomes would further enhance their profile, positioning them among top researchers in the field.

Prof. Dr Eman Atef | Pharmaceutical Science | Best Researcher Award |

Posted on by ScienceFather

Prof. Dr Eman Atef | Pharmaceutical Science | Best Researcher Award |

West Coast University,United States

Professional Profiles:

SCOPUS

ORCID

GOOGLE SCHOLAR

👨‍🎓 Bio Summary:

Prof. Dr. Eman Atef is an accomplished academic in the field of Pharmaceutics, Pharmacokinetics, and Pharmacogenomics, with a strong background in teaching, research, and leadership. With years of experience in both faculty and administrative roles, she has played a pivotal part in shaping the educational frameworks at various universities. Her work is centered on improving faculty development, enhancing curriculum design, and mentoring students and colleagues to reach their full potential.

🎓 Educational Background:

Prof. Dr. Atef holds a Ph.D. in Industrial Pharmacy and Pharmaceutics, with a minor in Pharmacology, from Massachusetts College of Pharmacy and Health Sciences (MCPHS) in Boston, MA (2004). She also earned an MSc in Industrial Pharmacy and Pharmaceutics from MCPHS (2001) and a B.Sc. in Pharmacy and Pharmaceutical Sciences from Cairo University, Egypt (1993), graduating with distinction and honors in the top 3% of her class.

🔍 Research Focus:

Her research primarily focuses on Pharmaceutics, Pharmacokinetics, and Pharmacogenomics. Dr. Atef has contributed to advancing knowledge in these areas, particularly in how pharmacogenomic insights can be applied to clinical practice. She has led research teams and mentored students at various levels, focusing on improving drug formulations and understanding the complex interactions between drugs and individual genetic factors.

🏆 Honors & Awards:

Dr. Atef’s dedication to education and research has been recognized with numerous accolades, including certificates in Leadership from the University of Pittsburgh’s Institute for Clinical Research Education (2017-2018) and Implementing Pharmacogenomics into Clinical Practice (2021) from the University of Florida. She has also received recognition for her extensive work in mentoring and her active participation in national academic committees.

💼 Professional Experience:

Prof. Dr. Atef is currently a faculty member at West Coast University School of Pharmacy in Los Angeles, CA, where she has been involved in various administrative roles. She has served as Chair of the Professional Development Committee (2020-2022) and is an active member of the Curriculum Committee. Her leadership extends to being the Faculty Representative on the Executive Committee (2021-2023), Vice Chair of the Assessment Committee (2021-present), and faculty mentor for assistant professors. In her previous position at California Northstate University, she was Chair of the Assessment Committee (2017-2019), leading efforts to improve the College Assessment Plan and student learning experiences.

📚 Top Noted Publications :

Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS)

Authors: E. Atef, A.A. Belmonte

Citations: 188

Journal: European Journal of Pharmaceutical Sciences

Volume/Issue: 35 (4), 257-263

Year of Publication: 2008

 

Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions

Authors: H. Chauhan, C. Hui-Gu, E. Atef

Citations: 128

Journal: Journal of Pharmaceutical Sciences

Volume/Issue: 102 (6), 1924-1935

Year of Publication: 2013

 

Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug–polymer interaction for synergistic effects

Authors: D. Prasad, H. Chauhan, E. Atef

Citations: 123

Journal: Journal of Pharmaceutical Sciences

Volume/Issue: 103 (11), 3511-3523

Year of Publication: 2014

 

Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction

Authors: H. Chauhan, A. Kuldipkumar, T. Barder, A. Medek, C.H. Gu, E. Atef

Citations: 87

Journal: Pharmaceutical Research

Volume: 31, 500-515

Year of Publication: 2014

 

Role of molecular interactions for synergistic precipitation inhibition of poorly soluble drug in supersaturated drug–polymer–polymer ternary solution

Authors: D. Prasad, H. Chauhan, E. Atef

Citations: 74

Journal: Molecular Pharmaceutics

Volume/Issue: 13 (3), 756-765

Year of Publication: 2016

Conclusion:

Eman Atef has a well-rounded profile with substantial leadership, mentoring, and teaching experience, making her a strong contender for the Best Researcher Award. Her active role in improving the educational experience of students and faculty, along with her research experience in Pharmaceutics and Pharmacogenomics, positions her as an excellent candidate. However, her research contributions could be further highlighted by focusing on the impact of her research outputs and increasing her international and public engagement.

Dr Shoaib Khan | Drug Designing Award | Best Researcher Award |

Posted on by ScienceFather

Dr. Shoaib Khan | Drug Designing Award |  Best Researcher Award.

Abbottabad University of Science and Technology ,Pakistan

Professional Profiles:

SCOPUS

GOOGLE SCHOLAR

👨‍🎓 Bio Summary:

Dr. Shoaib Khan is a dedicated professional with a Ph.D. in Organic Chemistry and a strong background in systems management. He is committed to using his education experience and computer skills to bring students into the twenty-first century. Dr. Khan’s research focuses on the design, synthesis, and biological evaluation of various organic compounds, with a particular interest in their potential applications in medicine and agriculture.

🎓 Education:

Dr. Khan completed his Ph.D. in Organic Chemistry from Hazara University, Mansehra, following his earlier degrees in Botany, Zoology, and Chemistry. He also holds a B.Ed. and M.Ed. in Science from Allama Iqbal Open University, Islamabad.

🔍 Research Focus:

Dr. Khan’s research primarily centers on the synthesis and evaluation of novel compounds with potential biological activities. His work often involves molecular docking studies and in vitro biological evaluations to assess the compounds’ efficacy against various targets, such as enzymes and cancer cells.

🏆 Honors & Awards:

Dr. Khan has received recognition for his research contributions, including awards for the quality and impact of his publications. He has also been honored for his teaching and supervisory roles in academia.

Professional Experience: 💼

Dr. Khan has extensive experience in academia, including supervising and mentoring students at various levels. He has served as an external examiner and has contributed significantly to the advancement of organic chemistry through his research and teaching.

📚 Top Noted Publications :

Title: Synthesis, in vitro α-amylase, α-glucosidase activities and molecular docking study of new benzimidazole bearing thiazolidinone derivatives
Authors: S Khan, H Ullah, F Rahim, M Nawaz, R Hussain, L Rasheed
Journal: Journal of Molecular Structure
Volume: 1269
Pages: 133812
Year: 2022
Citations: 42

 

Title: Synthesis, in vitro anti-microbial analysis and molecular docking study of aliphatic hydrazide-based benzene sulphonamide derivatives as potent inhibitors of α-glucosidase
Authors: S Khan, S Iqbal, M Shah, W Rehman, R Hussain, L Rasheed, H Alrbyawi, …
Journal: Molecules
Volume: 27
Issue: 20
Pages: 7129
Year: 2022
Citations: 36

 

Title: Multipotent cholinesterase inhibitors for the treatment of Alzheimer’s disease: Synthesis, biological analysis and molecular docking study of benzimidazole-based thiazole
Authors: R Hussain, H Ullah, F Rahim, M Sarfraz, M Taha, R Iqbal, W Rehman, …
Journal: Molecules
Volume: 27
Issue: 18
Pages: 6087
Year: 2022
Citations: 32

 

Title: Synthesis, DFT Studies, molecular docking and biological activity evaluation of thiazole-sulfonamide derivatives as potent Alzheimer’s inhibitors
Authors: S Khan, H Ullah, M Taha, F Rahim, M Sarfraz, R Iqbal, N Iqbal, R Hussain, …
Journal: Molecules
Volume: 28
Issue: 2
Pages: 559
Year: 2023
Citations: 28

 

Title: New biologically potent benzimidazole‐based‐triazole derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors along with molecular docking study
Authors: Y Khan, W Rehman, R Hussain, S Khan, A Malik, M Khan, A Liaqat, …
Journal: Journal of Heterocyclic Chemistry
Volume: 59
Issue: 12
Pages: 2225-2239
Year: 2022
Citations: 23

Title: Design, synthesis, in silico testing, and in vitro evaluation of thiazolidinone-based benzothiazole derivatives as inhibitors of α-amylase and α-glucosidase
Authors: S Khan, S Iqbal, M Khan, W Rehman, M Shah, R Hussain, L Rasheed, …
Journal: Pharmaceuticals
Volume: 15
Issue: 10
Pages: 1164
Year: 2022
Citations: 22

.Author Metrics 📊 : 

Dr. Khan’s publications have a significant impact factor, indicating the quality and influence of his research in the scientific community. His work has been cited by other researchers, further highlighting its importance and relevance.

📅 Research Timeline:

Dr. Khan’s research journey has been marked by a series of achievements, starting from his early education in science to his current position as a respected researcher and educator in the field of organic chemistry.